Welcome
to the second edition of the Lyndonville News.
It is with great joy that I would like to announce that we may soon
have a web site where access to the Lyndonville News
will be available at four in the morning for those of you with some
extra time on your hands at that time of night. It has taken a long
time, but I am now convinced that everyone needs a web site assigned
to them at birth. The production of the site is kindly being donated,
and hopefully we will be talking more about this in the next issue.
I am somewhat confused about sending out a newsletter
by e-mail. Yours may not arrive because of spam blocker technology,
and you will not even know it has been sent. Pictures and graphics
may not come through on the e-mail version. Some people may not have
access to e-mail. Finally, some people just like to sit and read through
their newsletters in the comfort of an armchair by the window. For
anyone who would like a hard copy of the newsletter sent by regular
mail, it is available for $20 per year. I anticipate that there will
be four to six issues per year. The e-mail version will be offered
without charge.
Notes
from the Farm
This is another section that I will add to the
Lyndonville News from time to time. Sometimes after
a day at the office, I like to sit on the porch and think about life.
Tonight I was thinking about the advice I gave a patient who had become
very ill with ME/CFS/FM. She has been unable to work for six months
now, and she misses her PhD level job very much. She is single and
does not own her lodging. Her private disability company has said
that they will not pay her disability benefits because they do not
think she is ill, basing their decision on the fact that she was recently
on an airplane. I have patients with terminal cancer who have been
on an airplane. She was terminated from her job because she has not
been at work for over six months. In the past I have written letters
stating unambiguously that she is disabled with chronic fatigue syndrome
and has no primary psychiatric disease. She asked me what she should
do.
She has two options. First she can appeal the denial
of benefits from her insurance company. She can get more testing to
establish the biologic basis of her illness. For example she could
get the 2-5’A synthetase level, the PCR for HHV6, cytokine levels
of TNF, and interferons; she could get a circulating blood volume
study, or orthostatic testing. She already has been found positive
for the fibromyalgia tender points. She could also get some of the
more expensive and newer research tests. But if she were to get them
all and all of these tests were abnormal, the insurance company would
still say that they will not pay her disability benefits. They would
say, “there is no proof of disability”. She can spend
the next few years with appeals, lawyers, tests, and, if it goes to
court three years from now, she may win her claim.
Her second option is to say, 'even though I have paid
into the private disability policy for nearly ten years, I should
cut my losses and drop it. I am too tired and sick to wage this war,
and it is just not worth the fight.'
I have no advice for her. She understands the dilemma
with a chilling clarity. In my opinion, the private insurance companies
have decided not to honor the promises they made in their disability
policies, and arbitrarily have decided to ignore the science that
exists around ME/CFS/FM. I think they have concluded that they will
be able to get away with it legally, and that the patients are too
sick and poor to wage a prolonged legal battle. It appears to me that
they will continue to follow this approach of saying that there is
no such disease as ME/CFS/FM. Perhaps they will say that even if the
illness exists, it is so minor or trivial that it does not cause disability
in a specific individual.
I do not know what my patient is going to do. It is
possible that she will go from a prestigious, well-paying job to losing
everything. It is likely to take her over two years to apply and get
social security benefits. She has no other means of support for the
coming two years. We talked about what life would be like while living
under an underpass. It is a good thing that she has not yet lost her
sense of humor. I wonder how much money she paid to the disability
company over the past ten years?
Tonight there are just discouraging thoughts while sitting
on the porch looking out on the north pasture. It is not always discouraging
or depressing, but tonight it is.
Rookie
Section
Let’s look at a few definitions that will be important
for the next several newsletters. And the rookies should not feel
bad because most of the old-timers do not know this stuff either.
In the remaining sections of this newsletter and in some of the issues
to follow we will be examining the possibility of the symptoms of
ME/CFS/FM being caused by autoimmunity, specifically autoantibodies
directed against the autonomic nervous system. This is not a new theory,
but it is one that is becoming more interesting recently.
The term autoimmunity means that the body’s immune
system (immunity) has made a mistake and is attacking itself (auto).
The form this takes is that the immune mechanism makes antibodies
against normal body tissues, called autoantibodies. In ME/CFS/FM the
immune system is generally overactive. People often think of the immune
system here as being deficient, and in a few areas such as the natural
killer cells it is deficient. But the over-riding problem in the illness
is that the immune response is over-aggressive, as if the body were
attacking a flu virus. This over-reactivity is one of the supporting
reasons that persistent viral infection continues to be considered
as a leading candidate for the cause of ME/CFS/FM. Think of it as
if the system were revved up and looking for something to attack.
In autoimmunity, the normal response goes too far and the immune system
ends up fighting with something that should not be attacked, healthy
body tissues.
Rheumatoid arthritis is an autoimmune disease. The
body’s immune system messes up and starts attacking healthy
joint tissue. This causes the swelling and pain of rheumatoid arthritis.
Lupus and multiple sclerosis are also autoimmune diseases, and there
are many others. To make a diagnosis of autoimmune disease, it is
necessary to isolate an autoantibody and show that it is causing the
symptoms of an illness.
Section
for the Old-timers
Over the coming months to years we will be returning
to a discussion of the autonomic nervous system in our discussion
of ME/CFS/FM. So I thought it would be a good idea to outline a little
of the structure or organization.
First there are two types of human nervous system. The
motor or voluntary system and the autonomic (or automatic) system.
The autonomic system is composed of two parts: central and peripheral.
The central autonomic system is composed of the ‘primitive’
parts of the brain and upper spinal cord that control heart rate,
blood pressure, body temperature, pain sensation, sweating, appetite,
and so on. The peripheral autonomic nervous system (ANS) consists
of the nerves going to the intestines, bladder, sweat gland, adrenal
glands, heart and so on.
There are two big divisions of the central and peripheral
autonomic nervous system, adrenergic and cholinergic. The adrenergic
system (sympathetic nervous system) is the ‘fight or flight’
response. It is run by adrenalin (epinephrine, noradrenalin) and mobilizes
the body automatically for an emergency like running away from a saber
tooth tiger. The cholinergic system (parasympathetic nervous system)
is run by acetylcholine (ACh) and this controls more subtle aspects
like sweating, sleep, pupil dilatation, concentration, intestine function
and so on.
Just to make life really complicated, the cholinergic
system is divided into two parts, the nicotinic and muscarinic system.
Each neurotransmitter (chemical which transmits the impulse across
nerve junctions) has one or more receptors. If it cheers any of you
up, I saw this in medical school and said that there was no way this
was ever going to be important, so I never learned it. So the last
five years….
Case
Reports
Amy T is a young lady who became ill while coming out
of a movie theater nine years ago. It is one of those things she remembers.
At the time, however, she assumed it was a minor infection: sore throat,
fever, swollen glands and flu-like aching. For a few days she rested
in bed and then saw her doctor who agreed it was a minor virus. A
few days later the mononucleosis test was run and it was positive.
Ah…. plan on two weeks of rest, fluids, and chicken soup.
Amy remained ill for the next two weeks and then she
got really sick. She said it was like being hit by a Mack truck. The
exhaustion and weakness were severe. Whereas before she was sick,
now she was really sick. Tests were run, and six months later she
began to improve slightly. She was diagnosed with chronic fatigue
syndrome. Now, eight years later she is doing pretty well, but the
symptoms continue.
Amy’s story is pretty characteristic of the acute
onset of ME/CFS/FM. But there is a clinical detail hidden which is
an important piece of the puzzle. Here is the issue:
One theory of the symptoms of CFS states that the cytokines
(tumor necrosis factor, interleukin, interferons) which are stimulated
by the initial infection get stuck in the “on” position
and continue to produce symptoms for the indefinite future. A second
theory says that an infection, (in this case mononucleosis) starts
and ongoing viral activity continues for years because some defect
in the immune system prevents the eradication of the infection. Amy’s
story, (which is true, by the way) proves both of these theories false.
Coming out of the movie theater she became ill with
mononucleosis. The cytokines began to be produced at that time. However
it was just the ordinary illness – fever, sore throat, tiredness,
muscle aching, and swollen glands. The “essence” of ME/CFS/FM,
which is the “hit by a Mack truck”, started suddenly two
weeks later. It could not have been the cytokines because they had
been circulating for the initial two to three weeks of the illness.
Something new had occurred at the two week point, the “hit by
a truck” phenomenon.
Furthermore, it could not be the viral infection. The
mono infection had been underway for two weeks before the worsening
occurred. Therefore it was not a result of viral persistence, it was
something new. There must be some other mechanism.
The logical explanation for me is that the mononucleosis
began a process that became apparent at the two week mark. The model
I like best is that the body developed an autoantibody to a part of
the autonomic nervous system that was the phenomenon of “being
hit by a truck.” There is an illness called Guillan-Barre syndrome
that is quite parallel except that the autoantibodies developed are
against the motor system and thus cause a true paralysis. The paralysis
starts at the feet and moves up the body. Usually it improves and
the person gets better. The Guillan-Barre syndrome is an autoimmune
disease and is not ME/CFS/FM.
If ME/CFS/FM were an autoimmune disease stimulated by
an acute infection, we do not know what the autoantibody is. But this
is an exciting area of research because there are now several autoantibodies
on the horizon. For now, with Amy’s case, we can just speculate
about this potential mechanism. But it may be that in a relatively
short period of time we will be able to measure certain autoantibodies,
and make a diagnosis of “autoimmune dysautonomia” following
mononucleosis. And hopefully we will then have specific treatments
which can reverse the process. For reasons that I have never understood,
people seem to think that I am an optimist.
It would be interesting to approach the question, the
biphasic onset, with a questionnaire. Maybe this would be a good project
for the Lyndonville Research
Group. But it is because of this possibility that I have
chosen to review a paper on autonomic autoimmunity in the next section.
Literature
Review
Article #1: Tanaka S, Kuratsune H, Hidaka
Y, Hakariya Y, Tatsumi K, Takano T, et al. Autoantibodies
against muscarinic cholinergic receptor in chronic fatigue syndrome.
International Journal of Molecular Medicine. 2003;12:225-230.
In this study, the authors examined blood samples of 60 patients
with chronic fatigue syndrome (CFS), 33 patients with known autoimmune
disease and 30 healthy control persons for autoantibodies to four
different neurotransmitter receptors. The one autoantibody most positive
in this study was to the recombinant human muscarinic cholinergic
receptor 1 (CHRM1), with 53.3% of the CFS patients positive. Of those
with known autoimmune disease, 15.2% were positive, and there were
no healthy controls positive. Because the symptoms of CFS could be
due to impaired cholinergic neurotransmission, this finding is extremely
interesting. This particular neurotransmitter receptor, CHRM1, is
in the brain and may be central to the symptoms of CFS. The authors
state, “positive reactions against CHRM1 in CFS patients may
play an important role in the clinical characteristics of CFS.”
Also of interest were the results of the testing for autoantibodies
against the mu-opoid receptor (OPRM1), and 15% of CFS patients were
positive against none of the controls. Given the prevalence of severe
pain in CFS, this needs to be looked at more carefully in future studies.
Comment: I am very surprised that this study has
not received more attention. If a patient with fatigue and weakness
tested positive for the acetylcholine receptor autoantibodies at the
neuromusclular junction, the diagnosis would be established as Myasthenia
gravis. Here we have over half of a group of CFS patients who appear
to have an autoimmune cholinergic dysautonomia. This study should
be replicated by other groups as soon as possible.
Article #2: Vernino S, Low P, VA L. Experimental
autoimmune autonomic neuropathy. J Neurophysiol 2003;90:2053-2059.
Autoantibodies to neuronal ganglionic nicotinic receptor have been
found in patients with autoimmune autonomic neuropathy (AAN). In this
paper the authors developed an animal model of autonomic failure by
immunizing rabbits with a portion of the ganglionic receptor. Following
this the animals developed autoantibodies to the receptor and then
developed dysautonomia, confirmed by examination of the nerve structure.
This model suggests that AAN in humans is a disorder of ganglionic
cholinergic synaptic transmission caused by nAChR antibodies.
Comment: One of the most important questions in
the subject of autoantibodies is whether the autoantibody found has
any relevance to the illness being studied. For example, antithyroid
peroxidase antibodies (autoantibodies against a component of thyroid
tissue) are found in 5% to 10% of healthy individuals. Therefore by
finding this particular autoantibody, it does not automatically follow
that the autoantibody has caused a disease. However in this study
they provide some evidence that autonomic failure, and in particular
autoimmune autonomic neuropathy or AAN, can be caused by autoantibodies
to the acetylcholine receptor.
It would be of great interest to know if patients with CFS have autoantibodies
directed against parts of the autonomic nervous system as the cause
of their illness, as is described in the first article. This is one
of those simple studies that would give us an enormous amount of information.
Imagine if one one-hundredth of the money spent on psychiatric studies
had been spent on medical studies like this where we would be.
So much for autoimmunity for now. It is a subject we will be returning
to over and over in the future because I feel it must be tied into
the mechanism of the illness. I apologize for the complexity of the
subject, and will work to make the next newsletter easier to read.
Please
.
Also, please send clinical questions that I can attempt to address.
The questions should be of a general nature and not personal.
General
DisclaimerAny medical advice that is
presented in the Lyndonville News is generic
and for general informational purposes only. ME/CFS/FM is an extremely
complex illness and any advice may not be appropriate for an individual
with this illness. Therefore, should you be interested or wish to
pursue any of the ideas presented here, please discuss them with your
personal physician.